A study on anticancer activity of tanshinone II A against human breast cancer

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 2, 2009, Pages 245-249

  Zhang, Pu Rong ^a   Lü, Qing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anshmone II A; Apoptosis fiction; Estrogen receptor; Growth inhibition; Positive intensity; Ureast cancer

Indexed keywords

ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; DNA; PHENANTHRENE DERIVATIVE; TANSHINONE;

APOPTOSIS; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; HUMAN; PATHOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; DITERPENES, ABIETANE; DNA, NEOPLASM; FEMALE; HUMANS; PHENANTHRENES; TUMOR CELLS, CULTURED;

EID: 63449089062     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Luo HW, Sun XR, Niwa M. Diterpenoids from Salvia paramihiorrhiza. Heterocycles, 1994 ;38( 11), 2473-2479.
2. CaoEH, Liu XQ, WangJJ, et al. Effect of natural antioxidant tanshinone H A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med,1996;20 (6):,801-806.
3. Xia WJ, Yang M, Fok TF, et al. Partial neuroprotective effect of pretreatment with tanshinone II A on neonatal hypoxia- ischemia brain damage. Pediatr Res,2005,58(4),784-790.
4. Chinese source
5. Chinese source
6. Yuan SL, Huang RM, Wang XJ, et al. Reversing effect of tanshinone on malignant phenotypes of human hepatocarcinoma cell line. World J Gastroenterology,1998;4(4) :317-319.
7. Yoon Y, Kim YO, Jeon WK, et al. Tanshione II A isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacology, 1999)68(1-3),121-127.
8. Chinese source
9. Wang XJ, Wei UQ. Yu SL, et al. Potential anticancer activity of tanshinone II A against human breast cancer. Int J Cancer, 2005,116(5),799-807.
10. Chinese source
11. Volm M, Koomagi R, Mattern J. Prognostic value of Basic Fibrablast Growth Factor and its Receptor (FGFR-1) in patients with non-small cell lung carcinomas. European Journal of Cancer,1997;33(4):691-693.
12. Chow LWC, Loo WTY. The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein (p21waf-l) and anti- apoptotic protein (bcl-2) in breast cancer cells. Breast Cancer Res Treat,2003;80(3),239-244.
13. Mukherjee AK, Basu S, Sarkar N, et al. Advances in cancer therapy with plant based natural products. Curr Med Chem, 2001;8(12):1467-1486.
14. Swami S, Raghavachari N, Muller UR, et al. Vitamin D growth inhibition of breast cancer cells, gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat,2003;80(1):249-262.
15. Rahko E, Blanco G, Soini Y, et al. A mutant TP53 gene status is associated with a poor prognosis and anthracycline- resistance in breast cancer patients. Eur J Cancer,2003;39(4): 447-453.
16. Chinese source
17. Zadrozny M, Smolarz B, Romanowicz Makowska H, et al. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer. Pol J Pathol,2002;53(4): 189-193.
18. Schippinger W, Regitnig P, Bauernhofer T, et al. The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer. Oncol Rep, 2004; 11 (6):1331-1336.
19. Abramenko IV, Filchenkov A A. Evaluation of apoptosis and diagnosis of cancer, prognosis and improvement of therapy. Vopr Onkol, 2003;49(1) : 21-30.